Dihydroartemisinin
Artenimol is an artemisinin derivative and antimalarial agent used in the treatment of uncomplicated *Plasmodium falciparum* infections. It was first authorized for market by the European Medicines Agency in October 2011 in combination with [DB13941] as the product Eurartesim. Artemisinin combination therapy is highly effective against malaria and stongly recommended by the World Health Organization.
| Catalog Number | PIPE-0693 |
| Alternative Name(s) | Artenimol Cotexin Dihydroqinghaosu |
| Research Area | Natural Extract |
| Molecular Formula | C15H24O5 |
| CAS# | 71939-50-9 |
| SMILES | CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)O)C |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/dihydroartemisinin-item-9632.html |